|
Volumn 19, Issue 2, 2003, Pages 102-106
|
Developing a patient pathway to deliver a new oral chemotherapy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
FLUOROURACIL;
ARTICLE;
CLINICAL PATHWAY;
HUMAN;
NEOPLASM;
ORAL DRUG ADMINISTRATION;
ORGANIZATION;
PATIENT CARE PLANNING;
ADMINISTRATION, ORAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
CRITICAL PATHWAYS;
FLUOROURACIL;
HUMANS;
NEOPLASMS;
ORGANIZATIONAL INNOVATION;
PATIENT CARE PLANNING;
|
EID: 0642372103
PISSN: 02668130
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|